Doppler Evaluation in RA Patients After Adalimumab.
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Adalimumab
Related studies linked through entity extraction aliases.
An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy
- Status
- COMPLETED
- Phase
- N/A
Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
- Status
- TERMINATED
- Phase
- PHASE3
Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.
- Status
- COMPLETED
- Phase
- PHASE2
Adalimumab-psoriasis and Small Bowel Lesions
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics and Safety Study of BI 695501 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE3
HUmira in Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
REstore Working Ability in RheumatoiD Arthritis
- Status
- UNKNOWN
- Phase
- PHASE4
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
- Status
- COMPLETED
- Phase
- N/A
Serum Concentration of Adalimumab as a Predictive Factor of Clinical Outcomes in Rheumatoid Arthritis (AFORA)
- Status
- COMPLETED
- Phase
- PHASE4
Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
- Status
- COMPLETED
- Phase
- PHASE3
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
- Status
- COMPLETED
- Phase
- PHASE4